Stage
Series A | AliveTotal Raised
$3MLast Raised
$3M | 9 yrs agoAbout VeriMed
VeriMed is a technology company that works to provide a secure, transparent and safe supply chain for controlled pharmaceutical substances. Through VeriMed's mix of technology and services, stakeholders along the controlled substances supply chain, including providers/doctors, wholesalers and pharmacists, may have access to HIPAA-compliant patient data that can be used to help mitigate the risk of substance abuse and drug diversion. There are four components to the VeriMed System: the VeriMed Information Portal, the VeriMed Patient Risk Assessment, the VeriMed Surveillance Pharmacy and the VeriPak.
Missing: VeriMed's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: VeriMed's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing VeriMed
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
VeriMed is included in 1 Expert Collection, including Pharma Supply Chain.
Pharma Supply Chain
1,258 items
VeriMed Patents
VeriMed has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/27/2013 | 2/24/2015 | Analog circuits, Computer memory, Resistive components, Electrical engineering, Electronic test equipment | Grant |
Application Date | 12/27/2013 |
|---|---|
Grant Date | 2/24/2015 |
Title | |
Related Topics | Analog circuits, Computer memory, Resistive components, Electrical engineering, Electronic test equipment |
Status | Grant |
Latest VeriMed News
Sep 25, 2013
VeriMed Raises $3M Led by Fortis Capital Updated Sept. 25, 2013 11:00 a.m. ET Join Now Sign In Members Only This is the kind of news coverage and analysis you can access exclusively as a WSJ Pro Member. Copyright 2016 Dow Jones & Company, Inc. All Rights Reserved This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.
VeriMed Frequently Asked Questions (FAQ)
What is VeriMed's latest funding round?
VeriMed's latest funding round is Series A.
How much did VeriMed raise?
VeriMed raised a total of $3M.
Who are the investors of VeriMed?
Investors of VeriMed include Fortis Capital Holdings.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.